A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and treatments, including chemotherapy.
CHICAGO — A blood test to detect cancer mutations produced results that generally agree with those of an invasive tumor biopsy, researchers reported, heralding a time when diagnosing cancer and ...
Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require removing a piece of tissue, a liquid biopsy typically looks for mutations ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
For the first time, fundamental tumor phenotypes determined by a simple blood test Single test now provides molecular tumor typing, subtyping and confirmation of absence of actionable biomarkers to ...
Fire, smoke, and the roar of a rocket engine blasted the Colorado prairie – the Ablative Mark 1 test was an exciting victory. A student club project at the University of Colorado Boulder, the static ...
A study assessing an experimental cell-free DNA myelination liquid biopsy test was found to be 91% accurate at identifying early-stage epithelial ovarian cancer. A recent analysis investigating the ...
Liquid biopsy tests are gaining traction within the industry as a viable alternative to traditional screening methods for cancer. A recent report by financial services firm Cowen & Co. said annual ...
A new study shows the cost-effectiveness of MDxHealth’s prostate cancer test. The Irvine, CA-based company’s SelectMDx is a liquid biopsy test that helps predict the likelihood that clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results